Showing results (361-370 of 389) with videos related to

Sort By:
Pageof 39
The New England Journal of Medicine|July 26, 2023
Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1Yves Dauvilliers, Emmanuel Mignot, Rafael Del Río Villegas, et al.
Nature Communications|August 5, 2014
Localized states in advanced dielectrics from the vantage of spin- and symmetry-polarized tunnelling across MgOF Schleicher, U Halisdemir, D Lacour, et al.
The New England Journal of Medicine|May 14, 2025
Oveporexton, an Oral Orexin Receptor 2-Selective Agonist, in Narcolepsy Type 1Yves Dauvilliers, Giuseppe Plazzi, Emmanuel Mignot, et al.
ACS Medicinal Chemistry Letters|January 25, 2021
Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357Christian Harcken, Johanna Csengery, Michael Turner, et al.
The Journal of Prevention of Alzheimer'S Disease|March 22, 2023
Investigating Partially Discordant Results in Phase 3 Studies of AducanumabC Mallinckrodt, Y Tian, P S Aisen, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 16, 2025
Genome Sequencing Uncovers Additional Findings in Phelan-McDermid SyndromeRachel Gore Moses, Morgan Similuk, Alexandra Hehn, et al.
The Journal of Prevention of Alzheimer'S Disease|May 11, 2022
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's DiseaseS Budd Haeberlein, P S Aisen, F Barkhof, et al.
Annals of Neurology|November 19, 2022
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated SyndromeDarin T Okuda, Orhun Kantarci, Christine Lebrun-Frénay, et al.
Pageof 39